10:07 EDT Opthea (OPT) Ltd (ADR) trading halted, news pending
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OPT:
- Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target
- Opthea announces Phase 2b Wet AMD publication
- Opthea Limited Reports Increased Losses Amid Clinical Advancements
- Opthea reports 1H adjusted EPS ($5.73) vs. ($14.25) last year
- Opthea announces anticipated milestones
Questions or Comments about the article? Write to editor@tipranks.com